Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [Off-label indications for topical tacrolimus].

Literature DB >> 24150824

[Off-label indications for topical tacrolimus].

Abstract

The topical calcineurin antagonist tacrolimus plays an important role in the treatment of different forms of eczema because of its favorable risk profile. In addition, different off-label indications have been clinically tested where tacrolimus ointment has achieved clinical improvement. This article discusses off-label treatment of vitiligo, seborrheic dermatitis, steroid rosacea, perioral dermatitis, rosacea and lichen sclerosus.

Entities: Chemical Disease

Mesh：

Substances：

Year: 2013 PMID： 24150824 DOI： 10.1007/s00105-013-2594-1

Source DB: PubMed Journal: Hautarzt ISSN： 0017-8470 Impact factor: 0.751

19 in total

1. Epithelial barrier function and atopic diathesis in rosacea and perioral dermatitis.

Authors: T Dirschka; H Tronnier; R Fölster-Holst
Journal: Br J Dermatol Date: 2004-06 Impact factor: 9.302

2. A randomized, placebo-controlled, double-blind trial comparing narrowband UV-B Plus 0.1% tacrolimus ointment with narrowband UV-B plus placebo in the treatment of generalized vitiligo.

Authors: Don Mehrabi; Amit G Pandya
Journal: Arch Dermatol Date: 2006-07

3. Tacrolimus ointment for the treatment of steroid-induced rosacea: a preliminary report.

Authors: D Goldman
Journal: J Am Acad Dermatol Date: 2001-06 Impact factor: 11.527

4. Safe and effective treatment of refractory facial lesions in atopic dermatitis using topical tacrolimus following corticosteroid discontinuation.

Authors: T Kawakami; Y Soma; E Morita; O Koro; S Yamamoto; K Nakamura; K Tamaki; K Yajima; A Imaizumi; R Matsunaga; N Murakami; M Kashima; M Mizoguchi
Journal: Dermatology Date: 2001 Impact factor: 5.366

5. Penile lichen sclerosus et atrophicus treated with clobetasol dipropionate 0.05% cream: a retrospective clinical and histopathological study.

Authors: K Dahlman-Ghozlan; M A Hedblad; G von Krogh
Journal: J Am Acad Dermatol Date: 1999-03 Impact factor: 11.527

Review 6. Adverse effects of topical glucocorticosteroids.

Authors: Ulrich R Hengge; Thomas Ruzicka; Robert A Schwartz; Michael J Cork
Journal: J Am Acad Dermatol Date: 2006-01 Impact factor: 11.527

7. Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines.

Authors: Pearl E Grimes; Robert Morris; Erik Avaniss-Aghajani; Teresa Soriano; Maria Meraz; Allan Metzger
Journal: J Am Acad Dermatol Date: 2004-07 Impact factor: 11.527

8. Tacrolimus ointment in the treatment of eyelid dermatitis.

Authors: Amy Krupnick Freeman; Janet Serle; Paul VanVeldhuisen; Leah Lind; Jan Clarke; Giselle Singer; Mark Lebwohl
Journal: Cutis Date: 2004-04

9. A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo.

Authors: Veronica Lepe; Benjamin Moncada; Juan Pablo Castanedo-Cazares; Maria Bertha Torres-Alvarez; Carlos A Ortiz; Antonio B Torres-Rubalcava
Journal: Arch Dermatol Date: 2003-05

10. Tacrolimus effect on rosacea.

Authors: Joel T M Bamford; Barbara A Elliott; Irina V Haller
Journal: J Am Acad Dermatol Date: 2004-01 Impact factor: 11.527

4 in total

Review 1. [Cutaneous Malassezia infections and Malassezia associated dermatoses: An update].

Authors: P Nenoff; C Krüger; P Mayser
Journal: Hautarzt Date: 2015-06 Impact factor: 0.751

2. Tacrolimus Suppositories in Therapy-Resistant Ulcerative Proctitis.

Authors: Simon U Jaeger; Thomas Klag; Katharina Hoeger; Siegfried Klumpp; Markus Escher; Nisar Malek; Eduard Stange; Jan Wehkamp
Journal: Inflamm Intest Dis Date: 2018-11-09

Review 3. Effectiveness and safety of topical tacrolimus monotherapy for repigmentation in vitiligo: a comprehensive literature review.

Authors: Andrea Sisti; Giovanni Sisti; Carlo Maria Oranges
Journal: An Bras Dermatol Date: 2016-04 Impact factor: 1.896

4. Combination therapy of orally administered glycyrrhizin and UVB improved active-stage generalized vitiligo.

Authors: K H Mou; D Han; W L Liu; P Li
Journal: Braz J Med Biol Res Date: 2016-07-25 Impact factor: 2.590

4 in total